LF

doc. MUDr. Zuzana Solárová, PhD.   SK

Email:
zuzana.solarova@upjs.sk
Homepage:
https://www.upjs.sk/LF/zamestnanec/zuzana.solarova
Faculty:
LF UPJŠ - Pavol Jozef Šafárik University in Košice Faculty of Medicine
Department:
UFR - Department of Pharmacology
Office:
Phone:
ORCID ID:
https://orcid.org/0000-0002-4212-5720
Doc. MUDr. Zuzana Solarova, PhD. is an associate professor of pharmacology at the UPJŠ Faculty of Medicine in Košice. She is a co-guarantor of the doctoral study program in medical pharmacology in the field of pharmacy. Her research focuses on the antitumor effect of natural substances or their synthetic derivatives, focusing on their influence of heat shock proteins (HSPs) by these substances and by their combinations with HSPs inhibitors as potential antitumor drugs. She has been continuously involved in solving projects in this area for 15 years. She is the author or co-author of 69 full-text scientific and professional publications published in domestic and foreign journals, which have been cited 147 times in the WoS / Scopus citation indexes. She is the co-author of three monographs and chapters in monographs and has participated in the preparation of two pharmacology textbooks for medical and pharmaceutical students.

Higher education and further qualification growth
Second degree of higher education:
LF UPJŠ, 1998, general medicine
Third degree of higher education:
UPJŠ LF, 2013, medical pharmacology
Associate professor:
LF UPJŠ, 2021, pharmacology

Research /art/ teacher profile

Display details  
Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
Study programme: medical pharmacology - 1,2, study field: pharmacy, member of the commission degree
Profile courses
pharmacology 2 - VL, I. + II. degree
pharmacology 2 - GM, I. + II. degree
pharmacology 2 - DM, I. + II. degree
medical pharmacology - PhD., III. degree
farmakológia 2 - ZL, I. + II. degree
Selected publications

ADC. Kimáková P. , Solár P. , Solárová Z. , Komel R. , Debeljak N. : Erythropoietin and its angiogenic activity. International Journal of Molecular Sciences. - ISSN 1422-0067. - Vol. 18, no. 7 (2017), art.no. 1519. (IF=3,687; Q1); cit. 37x

ADC: Zuzana Solárová, Martin Kello, Lenka Varinská, Marianna Budovská, Peter Solár : Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluorophenylamino)- 4H-1,3-thiazine[6,5-b]indole in A2780cis cells. Biomedicine & Pharmacotherapy. - ISSN 0753-3322. - Vol. 85 (2017), p. 463-471. (IF=3,457; Q1 - SJR) cit. 5 x.

Solár P. , Hrčková G. , Koptašíková L. , Velebný S. , Solárová Z. , Bačkor M. : Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: anticancer and hepatoprotective effects of atranorin in vivo. Chemico-Biological Interactions. - ISSN 0009-2797. - Vol. 250 (2016), s. 27-37, (IF=3,143; Q2) cit. 8x 

ADM: Solárová Z., Lisková A., Samec M., Kubatka P., Solár P.: Anticancer potential of lichens’ secondary metabolites. Biomolecules – ISSN 2218273X. – Vol. 10, no. 1 (2020), p. (IF=4,879; Q2 - JCR), cit. 26 x.

Selected projects

1. APVV-16-0446 Grant name: Cell interactions in tumor microenvironment ant its pharmacologic affecting. Grant supervisor: RNDr. Lenka Varinská, PhD. Duration: 1.7.2017-30.6.2021 Participation: member (2017-2021)

2.VEGA 1/0299/13 Grant name: The role of galectins in angiogenesis. Grant supervisor: RNDr. Lenka Varinská, PhD. Duration: 1.7.2013-30.6.2017 Participation: member (2013-2017)

3. VEGA 1/0394/15 Grant name: Erythropoietin receptor in mammary adenocarcinoma and its role in resistance to tamoxifen. Grant supervisor: Doc. RNDr. Peter Solár, PhD. Duration: 01/2015-12/2018 Participation: member (2015-2018)

4. VEGA 1/0536/19 Grant name: The role of erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo. Grant supervisor: Doc. RNDr. Peter Solár, PhD. Duration: 01/2019-12/2022 Participation: member (2019-till now)

International mobilities and visits
University in Ljubljana, Slovenia, Medical faculty of Ljubljana university, July of 2019, Erasmus teacher's mobility

Additional information

Projects
1. APVV-16-0446 Cell interactions in the tumor microenvironment and their pharmacological influence, member of the research team (2017-2021) 2. VEGA 1/0733/12 Typification of human erythropoietin receptor in cancer and normal cells, member of the research team (2012-2014) 3. VEGA 1/0394/15 Erythropoietin receptor in mammary adenocarcinoma and its role in resistance to tamoxifen, member of the research team (2015-2018) 4. VEGA 1/0536/19 The role of erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo, member of the research team (2019-untill now)
International collaboration
University of Ljubljana, Ľubľana , Slovinsko
Interesting links
www.biomednet.com www.elsevier.nl www.ncbi.nlm.nih.gov

Further information


LF